Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMCK28R)

Drug Name	Aerucin DMCK28R
Synonyms	AR-105; Monoclonal antibody (inhaler, Pseudomonas lung infection); Anti-P aeruginosa alginate antibody (dry powder inhalant formulation), Aridis; Monoclonal antibody (inhaler, Pseudomonas lung infection), Aridis
Drug Type	Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pneumocystis pneumonia	DISFSOM3	CA40.20	Phase 2	[1]
------------------------------------------------------------------------------------

1 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pseudomonas infection	DIS9WYLA	1B92	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03027609) Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin) in P. Aeruginosa Pneumonia. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT02486770) Study of Single Doses of IV Aerucin in Healthy Adults.